Tachycardia-mediated cardiomyopathy: Recognition and management

Current Heart Failure Reports

Volumn 6, Issue 4, 2009, Pages 257-264

  Olshansky, Brian ^a   Gopinathannair, Rakesh ^b   Sullivan, Renee M ^b  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DRONEDARONE;

ARTIFICIAL HEART PACEMAKER; ATRIOVENTRICULAR NODAL ABLATION; CARDIOMYOPATHY; CARDIOVERSION; CATHETER ABLATION; CLINICAL TRIAL; DISEASE COURSE; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HEART RHYTHM; HEART SURGERY; HOLTER MONITORING; HUMAN; PATHOPHYSIOLOGY; PROGNOSIS; REVIEW; RISK ASSESSMENT; SUDDEN DEATH; TACHYCARDIA; TACHYCARDIA MEDIATED CARDIOMYOPATHY;

ANTI-ARRHYTHMIA AGENTS; CARDIAC PACING, ARTIFICIAL; CARDIOMYOPATHIES; DIAGNOSIS, DIFFERENTIAL; ECHOCARDIOGRAPHY; HUMANS; MAGNETIC RESONANCE IMAGING; PROGNOSIS; TACHYCARDIA;

EID: 72449186744     PISSN: 15469530     EISSN: 15469549     Source Type: Journal    
DOI: 10.1007/s11897-009-0035-3     Document Type: Review

References (61)

1. S. Sbaity P. Nerheim B. Olshansky 2007 Heart failure and sudden death in patients with tachycardia-induced cardiomyopathy and recurrent tachycardia Cardiol Rev 247 46 49
2. A. Khasnis K. Jongnarangsin G. Abela, et al. 2005 Tachycardiainduced cardiomyopathy: a review of literature Pacing Clin Electrophysiol 28 710 721 10.1111/j.1540-8159.2005.00143.x 16008809 (Pubitemid 41001445)
3. P.L. Massoure P. Jais F. Sacher, et al. 2009 Tachycardia-induced right ventricular cardiomyopathy: epicardial radiofrequency ablation of an unusual and unexpected ventricular tachycardia J Cardiovasc Electrophysiol 20 813 817 10.1111/j.1540-8167.2008.01402.x 19207776
4. P. Nerheim S. Birger-Botkin L. Piracha B. Olshansky 2004 Heart failure and sudden death in patients with tachycardia-induced cardiomyopathy and recurrent tachycardia Circulation 110 247 252 10.1161/01.CIR.0000135472.28234.CC 15226218 (Pubitemid 38960795)
5. J.S. Shinbane M.A. Wood D.N. Jensen, et al. 1997 Tachycardiainduced cardiomyopathy: a review of animal models and clinical studies J Am Coll Cardiol 29 709 715 10.1016/S0735-1097(96)00592-X 1:STN:280:DyaK2s3is1ersA%3D%3D 9091514 (Pubitemid 27128241)
6. L. Calo E. De Ruvo A. Sette, et al. 2007 Tachycardia-induced cardiomyopathy: mechanisms of heart failure and clinical implications J Cardiovasc Med (Hagerstown) 8 138 143
7. J.A. Luchsinger J.S. Steinberg 1998 Resolution of cardiomyopathy after ablation of atrial flutter J Am Coll Cardiol 32 205 210 10.1016/S0735-1097(98) 00183-1 1:STN:280:DyaK1czjtF2gtg%3D%3D 9669271 (Pubitemid 28351063)
8. B. Singh U. Kaul K.K. Talwar, et al. 1996 Reversibility of "tachycardia induced cardiomyopathy" following the cure of idiopathic left ventricular tachycardia using radiofrequency energy Pacing Clin Electrophysiol 19 1391 1392 10.1111/j.1540-8159.1996.tb04222.x 1:STN:280:DyaK2s%2FjsFWmsw%3D%3D 8880807
9. I. Zupan P. Rakovec N. Budihna, et al. 1996 Tachycardia induced cardiomyopathy in dogs; relation between chronic supraventricular and chronic ventricular tachycardia Int J Cardiol 56 75 81 10.1016/0167-5273(96)02728-3 1:STN:280:DyaK2s%2Fks1yrtQ%3D%3D 8891808
10. C. Medi J.M. Kalman H. Haqqani, et al. 2009 Tachycardia-mediated cardiomyopathy secondary to focal atrial tachycardia: long-term outcome after catheter ablation J Am Coll Cardiol 53 1791 1797 10.1016/j.jacc.2009.02.014 19422986
11. G.W. Moe R.J. Howard E.A. Grima, et al. 1995 How does intermittent pacing modify the response to rapid ventricular pacing in experimental heart failure? J Card Fail 1 223 228 10.1016/1071-9164(95)90028-4 1:STN:280: DyaK1c%2Fot1ahtw%3D%3D 9420655
12. F.A. Tibayan D.T. Lai T.A. Timek, et al. 2002 Alterations in left ventricular torsion in tachycardia-induced dilated cardiomyopathy J Thorac Cardiovasc Surg 124 43 49 10.1067/mtc.2002.121299 12091807
13. P. Noe V. Van Driel F. Wittkampf, et al. 2002 Rapid recovery of cardiac function after catheter ablation of persistent junctional reciprocating tachycardia in children Pacing Clin Electrophysiol 25 191 194 10.1046/j.1460-9592.2002.00191.x 11915986
14. F. Anselme N. Boyle M. Josephson 1998 Incessant fascicular tachycardia: a cause of arrhythmia induced cardiomyopathy Pacing Clin Electrophysiol 21 760 763 10.1111/j.1540-8159.1998.tb00135.x 1:STN:280:DyaK1c3ksFarug%3D%3D 9584309 (Pubitemid 28197000)
15. F. Bogun T. Crawford S. Reich, et al. 2007 Radiofrequency ablation of frequent, idiopathic premature ventricular complexes: comparison with a control group without intervention Heart Rhythm 4 863 867 10.1016/j.hrthm.2007.03.003 17599667 (Pubitemid 46959198)
16. X.K. Liu B.J. Gersh Y.M. Cha 2008 Cardiomyopathy induced by pulmonary vein tachycardia cured by catheter ablation Nat Clin Pract Cardiovasc Med 5 406 410 10.1038/ncpcardio1243 18521108 (Pubitemid 351935574)
17. P.F. Winum G. Cayla M. Rubini, et al. 2009 A case of cardiomyopathy induced by inappropriate sinus tachycardia and cured by ivabradine Pacing Clin Electrophysiol 32 942 944 10.1111/j.1540-8159.2009.02414.x 19572874
18. Y. Kuramochi X. Guo D.B. Sawyer, et al. 2006 Rapid electrical stimulation induces early activation of kinase signal transduction pathways and apoptosis in adult rat ventricular myocytes Exp Physiol 91 773 780 10.1113/expphysiol. 2006.033894 1:CAS:528:DC%2BD28XoslGjtLk%3D 16675497 (Pubitemid 43944649)
19. M. Takahashi H. Tsutsui S. Kinugawa, et al. 1998 Role of microtubules in the contractile dysfunction of myocytes from tachycardia-induced dilated cardiomyopathy J Mol Cell Cardiol 30 1047 1057 10.1006/jmcc.1998.0674 1:CAS:528:DyaK1cXjslOmu78%3D 9618245 (Pubitemid 28279317)
20. M.L. Coker C.V. Thomas M.J. Clair, et al. 1998 Myocardial matrix metalloproteinase activity and abundance with congestive heart failure Am J Physiol 274 H1516 H1523 1:CAS:528:DyaK1cXjsVyqur0%3D 9612358
21. J. Kajstura X. Zhang Y. Liu, et al. 1995 The cellular basis of pacing-induced dilated cardiomyopathy. myocyte cell loss and myocyte cellular reactive hypertrophy Circulation 92 2306 2317 1:STN:280:DyaK28%2FhsleisA%3D%3D 7554216
22. J.L. Zellner F.G. Spinale D.M. Eble, et al. 1991 Alterations in myocyte shape and basement membrane attachment with tachycardiainduced heart failure Circ Res 69 590 600 1:STN:280:DyaK3MzjvFansQ%3D%3D 1873861
23. F.G. Spinale J.L. Zellner W.S. Johnson, et al. 1996 Cellular and extracellular remodeling with the development and recovery from tachycardia-induced cardiomyopathy: changes in fibrillar collagen, myocyte adhesion capacity and proteoglycans J Mol Cell Cardiol 28 1591 1608 10.1006/jmcc.1996.0150 1:CAS:528:DyaK28XlsF2jt7w%3D 8877770 (Pubitemid 26302217)
24. M. Mahmoudabady M. Mathieu L. Dewachter, et al. 2008 Activin-A, transforming growth factor-beta, and myostatin signaling pathway in experimental dilated cardiomyopathy J Card Fail 14 703 709 10.1016/j.cardfail.2008.05.003 1:CAS:528:DC%2BD1cXhtFOrtLjI 18926443
25. F.G. Spinale D.A. Hendrick F.A. Crawford, et al. 1990 Chronic supraventricular tachycardia causes ventricular dysfunction and subendocardial injury in swine Am J Physiol 259 H218 H229 1:STN:280:DyaK3czivVeisw%3D%3D 2375409
26. C. Omichi T. Tanaka Y. Kakizawa, et al. 2009 Improvement of cardiac function and neurological remodeling in a patient with tachycardia-induced cardiomyopathy after catheter ablation J Cardiol 54 134 138 10.1016/j.jjcc.2008. 10.002 19632533
27. P.M. Deshmukh R. Krishnamani M. Romanyshyn, et al. 2004 Association of angiotensin converting enzyme gene polymorphism with tachycardia cardiomyopathy Int J Mol Med 13 455 458 1:CAS:528:DC%2BD2cXitFams7c%3D 14767579
28. K. Ishibashi T. Osamura Y. Yamahara 2009 Myocardial stunning with partial aneurysmal formation generated during the recovering process of tachycardia-induced cardiomyopathy J Cardiol 54 121 127 10.1016/j.jjcc.2008.10. 001 19632531
29. M. Eronen 1997 Outcome of fetuses with heart disease diagnosed in utero Arch Dis Child Fetal Neonatal Ed 77 F41 F46 10.1136/fn.77.1.F41 1:STN:280:DyaK2svisFWgsA%3D%3D 9279182
30. S.N. Chiu C.W. Lu C.W. Chang, et al. 2009 Radiofrequency catheter ablation of supraventricular tachycardia in infants and toddlers Circ J 73 1717 1721 10.1253/circj.CJ-09-0123 19609044
31. J.J. Gallagher 1985 Tachycardia and cardiomyopathy: the chicken-egg dilemma revisited J Am Coll Cardiol 6 1172 1173 1:STN:280:DyaL28%2FgvFehtw%3D%3D 3876364
32. Y.H. Jeong K.J. Choi J.M. Song, et al. 2008 Diagnostic approach and treatment strategy in tachycardia-induced cardiomyopathy Clin Cardiol 31 172 178 10.1002/clc.20161 18404727 (Pubitemid 351556483)
33. G. Dandamudi A.Y. Rampurwala J. Mahenthiran, et al. 2008 Persistent left ventricular dilatation in tachycardia-induced cardiomyopathy patients after appropriate treatment and normalization of ejection fraction Heart Rhythm 5 1111 1114 10.1016/j.hrthm.2008.04.023 18675220
34. H.R. Middlekauff W.G. Stevenson L.W. Stevenson 1991 Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients Circulation 84 40 48 1:STN:280:DyaK3M3osVentA%3D%3D 2060110
35. P.C. Deedwania B.N. Singh K. Ellenbogen, et al. 1998 Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the Veterans Affairs Congestive Heart Failure Survival Trial of Antiarrhythmic Therapy (CHF-STAT). The Department of Veterans Affairs CHFSTAT Investigators Circulation 98 2574 2579 1:CAS:528:DyaK1MXlvVek 9843465
36. R. Farshi D. Kistner J.S. Sarma, et al. 1999 Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens J Am Coll Cardiol 33 304 310 10.1016/S0735-1097(98)00561-0 1:CAS:528:DyaK1MXivFersr8%3D 9973007 (Pubitemid 29234189)
37. B. Olshansky L.E. Rosenfeld A.L. Warner, et al. 2004 The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: approaches to control rate in atrial fibrillation J Am Coll Cardiol 43 1201 1208 10.1016/j.jacc.2003.11.032 15063430 (Pubitemid 38452597)
38. I.C. Van Gelder D.G. Wyse M.L. Chandler, et al. 2006 Does intensity of rate-control influence outcome in atrial fibrillation? An analysis of pooled data from the RACE and AFFIRM studies Europace 8 935 942 10.1093/europace/eul106 16973686 (Pubitemid 44614202)
39. I.C. Van Gelder D.J. Van Veldhuisen H.J. Crijns, et al. 2006 Rate Control Efficacy in permanent atrial fibrillation: a comparison between lenient versus strict rate control in patients with and without heart failure. Background, aims, and design of RACE II Am Heart J 152 420 426 10.1016/j.ahj.2006.02.033 16923407 (Pubitemid 44233429)
40. V. Fuster L.E. Ryden D.S. Cannom, et al. 2006 ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (writing committee to revise the 2001 guidelines for the management of patients with atrial fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Circulation 114 e257 e354 10.1161/CIRCULATIONAHA.106.177292 16908781 (Pubitemid 44252297)
41. C. Narasimhan Z. Blanck M. Akhtar 1998 Atrioventricular nodal modification and atrioventricular junctional ablation for control of ventricular rate in atrial fibrillation J Cardiovasc Electrophysiol 9 S146 S150 1:STN:280:DyaK1czpsVKksQ%3D%3D 9727690
42. H. Yamada Z.B. Popovic D.O. Martin, et al. 2006 The effects of altering time delays of coupled pacing during acute atrial fibrillation Heart Rhythm 3 722 727 10.1016/j.hrthm.2006.02.007 16731478 (Pubitemid 43758260)
43. S.B. Botkin L.S. Dhanekula B. Olshansky 2003 Outpatient cardioversion of atrial arrhythmias: efficacy, safety, and costs Am Heart J 145 233 238 10.1067/mhj.2003.112 12595839 (Pubitemid 36207943)
44. R. Gopinathannair B. Olshansky 2009 Ibutilide revisited: stronger and safer than ever Europace 11 9 10 10.1093/europace/eun337 19088363
45. D. Roy M. Talajic P. Dorian, et al. 2000 Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators N Engl J Med 342 913 920 10.1056/NEJM200003303421302 1:CAS:528: DC%2BD3cXisFWmt7s%3D 10738049 (Pubitemid 30177051)
46. D. Roy M. Talajic S. Nattel, et al. 2008 Rhythm control versus rate control for atrial fibrillation and heart failure N Engl J Med 358 2667 2677 10.1056/NEJMoa0708789 1:CAS:528:DC%2BD1cXns1Wrtr0%3D 18565859 (Pubitemid 351860859)
47. S.H. Hohnloser H.J. Crijns M. van Eickels, et al. 2009 Effect of dronedarone on cardiovascular events in atrial fibrillation N Engl J Med 360 668 678 10.1056/NEJMoa0803778 1:CAS:528:DC%2BD1MXhvVyisbg%3D 19213680
48. L. Kober C. Torp-Pedersen J.J. McMurray, et al. 2008 Increased mortality after dronedarone therapy for severe heart failure N Engl J Med 358 2678 2687 10.1056/NEJMoa0800456 18565860 (Pubitemid 351860860)
49. L.F. Hsu P. Jais P. Sanders, et al. 2004 Catheter ablation for atrial fibrillation in congestive heart failure N Engl J Med 351 2373 2383 10.1056/NEJMoa041018 1:CAS:528:DC%2BD2cXhtVCrtrrE 15575053
50. M.N. Khan P. Jais J. Cummings, et al. 2008 Pulmonary-vein isolation for atrial fibrillation in patients with heart failure N Engl J Med 359 1778 1785 10.1056/NEJMoa0708234 1:CAS:528:DC%2BD1cXht12nu73J 18946063
51. P.H. Pak H.B. Nuss R.S. Tunin, et al. 1997 Repolarization abnormalities, arrhythmia and sudden death in canine tachycardia-induced cardiomyopathy J Am Coll Cardiol 30 576 584 10.1016/S0735-1097(97)00193-9 1:STN:280: DyaK2szptVKkug%3D%3D 9247535 (Pubitemid 27339341)
52. M.R. Afonso H.H. Franca 1992 Sudden death and tachycardiomyopathy in a young man with incessant tachycardia Arq Bras Cardiol 58 303 306 1:STN:280:DyaK2c%2FlvVOjtw%3D%3D 1340700
53. H. Watanabe K. Okamura M. Chinushi, et al. 2008 Clinical characteristics, treatment, and outcome of tachycardia induced cardiomyopathy Int Heart J 49 39 47 10.1536/ihj.49.39 1:CAS:528:DC%2BD1cXltFOktb4%3D 18360063 (Pubitemid 351688297)
54. K. Fox J.S. Borer A.J. Camm, et al. 2007 Resting heart rate in cardiovascular disease J Am Coll Cardiol 50 823 830 10.1016/j.jacc.2007.04.079 17719466 (Pubitemid 47277500)
55. J. Hsia J.C. Larson J.K. Ockene, et al. 2009 Resting heart rate as a low tech predictor of coronary events in women: prospective cohort study BMJ 338 b219 10.1136/bmj.b219 19193613
56. U.E. Heidland B.E. Strauer 2001 Left ventricular muscle mass and elevated heart rate are associated with coronary plaque disruption Circulation 104 1477 1482 10.1161/hc3801.096325 1:STN:280:DC%2BD3MrisVWhtA%3D%3D 11571239
57. P. Palatini S. Julius 2004 Elevated heart rate: a major risk factor for cardiovascular disease Clin Exp Hypertens 26 637 644 10.1081/CEH-200031959 1:STN:280:DC%2BD2M%2FntlKlug%3D%3D 15702618 (Pubitemid 40129752)
58. X. Jouven J.P. Empana P.J. Schwartz, et al. 2005 Heart-rate profile during exercise as a predictor of sudden death N Engl J Med 352 1951 1958 10.1056/NEJMoa043012 1:CAS:528:DC%2BD2MXjvFyrtrc%3D 15888695 (Pubitemid 40638365)
59. K. Fox I. Ford P.G. Steg, et al. 2008 Heart rate as a prognostic risk factor in patients with coronary artery disease and leftventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial Lancet 372 817 821 10.1016/S0140-6736(08)61171-X 18757091
60. P.M. Okin K. Wachtell S.E. Kjeldsen, et al. 2008 Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study Circ Arrhyth Electrophysiol 1 337 343 10.1161/CIRCEP.108.795351 1:CAS:528:DC%2BD1cXhsVKqsrbN
61. R. Gopinathannair R.M. Sullivan B. Olshansky 2008 Slower heart rates for healthy hearts: time to redefine tachycardia? Circ Arrhythm Electrophysiol 1 321 323 10.1161/CIRCEP.108.835264 19808425